ReviewThe Korean journal of helicobacter and upper gastrointestinal research2025
Infective Esophagitis.
Review in The Korean journal of helicobacter and upper gastrointestinal research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infectious esophagitis is caused by a viral, fungal, or bacterial infection of the esophagus. The most common viral pathogens are cytomegalovirus (CMV) and herpes simplex virus (HSV); Candida is the most common fungal pathogen. Bacterial esophagitis is rare, typically occurring only in immunocompromised individuals, and is often caused by the reactivation of a latent infection. The symptoms of infectious esophagitis range from an asymptomatic presentation to dysphagia, chest pain, and fever. Diagnoses are based on endoscopic findings and biopsy results for pathogen identification. In immunocompromised patients, treatment involves the use of antimicrobial agents. CMV esophagitis is characterized by esophageal ulcers visible during endoscopy and is diagnosed when intranuclear or cytoplasmic inclusions are observed in biopsy samples. Patients with HSV esophagitis present with volcano-like ulcers visible during endoscopy and are treated with acyclovir. Candida esophagitis is identified by the presence of white plaques and is treated using fluconazole. Although rare, bacterial esophagitis can be caused by Mycobacterium tuberculosis or oral/respiratory tract bacteria. This form of infectious esophagitis presents as nonspecific esophagitis during endoscopy; patients are treated using antibiotics. This review discusses the causative pathogens, endoscopic features, diagnosis, and treatment of infectious esophagitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.